Pharmafile Logo

News and Press Releases

Upperton Continues Strategic Growth with the Appointment of Michael Mellor-Clark as Chief Commercial Officer.

9 April 2025 – Nottingham, UK – Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), continues its growth following the build of a new sterile manufacturing...

Category:
Posted: April 9, 2025

Upperton Pharma Solutions
contact@upperton.com
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN

Seaport Therapeutics Names Lauren White as Chief Financial Officer

November 5, 2024 – Boston, MA, US – Seaport Therapeutics (“Seaport or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team,...

Category: Biotechnology
Posted: November 5, 2024

Seaport Therapeutics
info@seaporttx.com
6 Tide Street, Suite 400, Seaport Boston, MA 02210

Hays appoints new Global Head of Life Sciences

18 October 2024 – London, UK – Hays, the global leader in workforce solutions and specialist recruitment, is pleased to announce the appointment of James Nyssen as Global Head of...

Category: Pharmaceutical
Posted: October 22, 2024

Hays
Hays plc 4th Floor 20 Triton Street Regent's Place London NW1 3BF

Asymchem welcomes Franck Mevellec as senior director of Business Development

29 May 2024 -- Paris, France --  Asymchem, a leading global CDMO, is excited to announce the appointment of Franck Mevellec as senior director of business development. Franck brings over...

Category: BioManufacturing, Drug Discovery, Pharmaceutical
Posted: May 29, 2024

Asymchem
inquiry@asymchem.com
Asymchem Laboratories (Tianjin) Co., Ltd No. 6 Dongting 3rd Avenue, TEDA Tianjin, 300457, P.R. China

Sphere Fluidics appoints Curtis Nicholson as director of Sales, EMEA, to support accelerated growth in key markets

23 May 2024 -- Cambridge, UK -- Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Curtis Nicholson as director...

Category: Biotechnology, Pharmaceutical
Posted: May 23, 2024

Sphere Fluidics
info@spherefluidics.com
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom

Closed Loop Medicine appoints Paul Johnson as Non-Executive Director

Appointment of digital healthcare leader to Board to support the company as it enters next phase of commercial development Co-founder and former CEO of Lemonaid Health, a leading innovator in...

Category: Biotechnology, Pharmaceutical
Posted: May 22, 2024

Closed Loop Medicine
info@closedloopmedicine.com
Babraham Research Campus Cambridge CB22 3AT United Kingdom

X‑Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery Strategy 

2 April 2024 -- Massachusetts, US -- X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the addition of Dr Erin Davis as chief technology officer....

Category: Drug Discovery
Posted: April 2, 2024

X-Chem
info@x-chemrx.com
100 Beaver Street Waltham, MA 02453

Arriello appoints experienced biotech expert, Kate Coleman, as VP of Quality & Compliance 

The prestigious senior appointment comes as ambitious ATMP/innovative product companies continue to choose Arriello for holistic Regulatory/Quality services adapted to clients’ needs   20 September 2023 -- Dublin, Ireland --...

Category: Other
Posted: September 21, 2023

Arriello
solutions@arriello.com
No. 51, Bracken Road, Sandyford, Dublin D18 CV48 Ireland

Phastar Appoints Graham Clark as New Chief Executive Officer

Phastar Sets Course for Further Growth with New CEO Appointment 10 August 2023 -- London, UK, and North Carolina, US -- Phastar, a global specialist biometrics contract research organisation (CRO),...

Category: Clinical Trials
Posted: August 17, 2023

PHASTAR
tellmemore@phastar.com
Unit 2, 2A Bollo Ln, Chiswick, London W4 5LE